Evidence map›Paper›PMID 25983215›Full record

SynthesisOphthalmology2015

Increasing Prevalence of Myopia in Europe and the Impact of Education.

Katie M Williams, Geir Bertelsen, Phillippa Cumberland, Christian Wolfram, Virginie J M Verhoeven, Eleftherios Anastasopoulos, Gabriëlle H S Buitendijk, Audrey Cougnard-Grégoire, Catherine Creuzot-Garcher, Maja Gran Erke and 25 more

Open access · hybridAbstract readMeta-Analysis
In one paragraph

Synthesis in Ophthalmology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 245 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
245citing papers in PubMed, 11 pooled it
24.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

245 citing papers in PubMed, 11 syntheses or guidelines pooled it, 480 citations in OpenAlex.

  1. Analysing myopia in Europe: A comprehensive meta-analysis.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Efficacy of spectacle lenses specifically designed for myopia control: systematic review and meta-analysis.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2025
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Myopia and Near Work: A Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2023
    Pooled it
  9. Regional variations and temporal trends of childhood myopia prevalence in Africa: A systematic review and meta-analysis.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2022
    Pooled it
  10. Pooled it
  11. Pooled it
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Prevalence of myopia and myopia trends among optometric telemedicine users in Spain: a retrospective nationwide observational study.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  20. Exploring Characteristics and Systemic Health Links in Myopic Australian Adults.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2026
    Article

185 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

35 authors at 18 institutions in 6 countries.

Katie M WilliamsDepartment of Ophthalmology, King's College London, St. Thomas' Hospital, London, United Kingdom; Department of Twin Research and Genetic Epidemiology, King's College London, St. Thomas' Hospital, London, United Kingdom.
Geir BertelsenDepartment of Ophthalmology, University Hospital of North Norway, Tromsø, Norway; Department of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.
Phillippa CumberlandLife Course, Epidemiology and Biostatistics Section, UCL Institute of Child Health, London, United Kingdom.
Christian WolframUniversity Medical Center, Department of Ophthalmology, Mainz, Germany.
Virginie J M VerhoevenDepartment of Ophthalmology, Erasmus Medical Center, Rotterdam, The Netherlands; Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Eleftherios AnastasopoulosDepartment of Ophthalmology, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Gabriëlle H S BuitendijkDepartment of Ophthalmology, Erasmus Medical Center, Rotterdam, The Netherlands; Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Audrey Cougnard-GrégoireUniversity Bordeaux, Bordeaux, France; ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France.
Catherine Creuzot-GarcherDepartment of Ophthalmology, Eye and Nutrition Research Group UMR 1324 INRA, University Hospital Dijon, France.
Maja Gran ErkeDepartment of Ophthalmology, Oslo University Hospital, Oslo, Norway.
Ruth HoggCentre for Experimental Medicine, Institute of Clinical Science, Queen's University Belfast, Belfast, United Kingdom.
René HöhnUniversity Medical Center, Department of Ophthalmology, Mainz, Germany.
Pirro HysiDepartment of Twin Research and Genetic Epidemiology, King's College London, St. Thomas' Hospital, London, United Kingdom.
Anthony P KhawajaDepartment of Public Health and Primary Care, Institute of Public Health, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.
Jean-François KorobelnikUniversity Bordeaux, Bordeaux, France; ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France.
Janina RiedInstitute of Genetic Epidemiology, Helmholtz Center Munich, German Research Center for Environmental Health, Neuherberg, Germany.
Johannes R VingerlingDepartment of Ophthalmology, Erasmus Medical Center, Rotterdam, The Netherlands; Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Alain BronDepartment of Ophthalmology, Eye and Nutrition Research Group UMR 1324 INRA, University Hospital Dijon, France.
Jean-François DartiguesUniversity Bordeaux, Bordeaux, France; ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France.
Astrid FletcherLondon School of Hygiene and Tropical Medicine, London, United Kingdom.
Albert HofmanDepartment of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Robert W A M KuijpersDepartment of Ophthalmology, Erasmus Medical Center, Rotterdam, The Netherlands; Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Robert N LubenDepartment of Public Health and Primary Care, Institute of Public Health, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.
Konrad OxeleInstitute of Human Genetics, Klinikum rechts der Isar, Technische Universität, Munich, Germany.
Fotis TopouzisDepartment of Ophthalmology, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Therese von HannoDepartment of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway; Department of Ophthalmology, Nordland Hospital, Norway, Bodø, Norway.
Alireza MirshahiUniversity Medical Center, Department of Ophthalmology, Mainz, Germany.
Paul J FosterNIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust & UCL Institute of Ophthalmology, London, United Kingdom.
Cornelia M van DuijnDepartment of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Norbert PfeifferUniversity Medical Center, Department of Ophthalmology, Mainz, Germany.
Cécile DelcourtUniversity Bordeaux, Bordeaux, France; ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France.
Caroline C W KlaverDepartment of Ophthalmology, Erasmus Medical Center, Rotterdam, The Netherlands; Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Jugnoo RahiLife Course, Epidemiology and Biostatistics Section, UCL Institute of Child Health, London, United Kingdom; NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust & UCL Institute of Ophthalmology, London, United Kingdom.
Christopher J HammondDepartment of Ophthalmology, King's College London, St. Thomas' Hospital, London, United Kingdom; Department of Twin Research and Genetic Epidemiology, King's College London, St. Thomas' Hospital, London, United Kingdom. Electronic address: chris.hammond@kcl.ac.uk.
European Eye Epidemiology (E(3)) Consortium
Erasmus MC · NLJohannes Gutenberg University Mainz · DEUniversité de Bordeaux · FRAristotle University of Thessaloniki · GRSt Thomas' Hospital · GBUniversity College London · GBUniversity of Cambridge · GBHelmholtz Zentrum München · DEInserm · FRKing's College London · GBLondon School of Hygiene & Tropical Medicine · GBMoorfields Eye Hospital NHS Foundation Trust · GBNordland Hospital · NOOslo University Hospital · NOQueen's University Belfast · GBTechnical University of Munich · DEUniversity Hospital of North Norway · NOUniversity Medical Center of the Johannes Gutenberg University Mainz · DE

Funding

Department of Health SRF/01/010Medical Research Council G0000934Medical Research Council G0400546Medical Research Council G0401527Medical Research Council G1000143Medical Research Council MR/K023721/1
6 · The paper itself

Abstract

purposeTo investigate whether myopia is becoming more common across Europe and explore whether increasing education levels, an important environmental risk factor for myopia, might explain any temporal trend.

designMeta-analysis of population-based, cross-sectional studies from the European Eye Epidemiology (E(3)) Consortium.

participantsThe E(3) Consortium is a collaborative network of epidemiological studies of common eye diseases in adults across Europe. Refractive data were available for 61 946 participants from 15 population-based studies performed between 1990 and 2013; participants had a range of median ages from 44 to 78 years.

methodsNoncycloplegic refraction, year of birth, and highest educational level achieved were obtained for all participants. Myopia was defined as a mean spherical equivalent ≤-0.75 diopters. A random-effects meta-analysis of age-specific myopia prevalence was performed, with sequential analyses stratified by year of birth and highest level of educational attainment.

main outcome measuresVariation in age-specific myopia prevalence for differing years of birth and educational level.

resultsThere was a significant cohort effect for increasing myopia prevalence across more recent birth decades; age-standardized myopia prevalence increased from 17.8% (95% confidence interval [CI], 17.6-18.1) to 23.5% (95% CI, 23.2-23.7) in those born between 1910 and 1939 compared with 1940 and 1979 (P = 0.03). Education was significantly associated with myopia; for those completing primary, secondary, and higher education, the age-standardized prevalences were 25.4% (CI, 25.0-25.8), 29.1% (CI, 28.8-29.5), and 36.6% (CI, 36.1-37.2), respectively. Although more recent birth cohorts were more educated, this did not fully explain the cohort effect. Compared with the reference risk of participants born in the 1920s with only primary education, higher education or being born in the 1960s doubled the myopia prevalence ratio-2.43 (CI, 1.26-4.17) and 2.62 (CI, 1.31-5.00), respectively-whereas individuals born in the 1960s and completing higher education had approximately 4 times the reference risk: a prevalence ratio of 3.76 (CI, 2.21-6.57).

conclusionsMyopia is becoming more common in Europe; although education levels have increased and are associated with myopia, higher education seems to be an additive rather than explanatory factor. Increasing levels of myopia carry significant clinical and economic implications, with more people at risk of the sight-threatening complications associated with high myopia.

Indexed as

Educational StatusAdultAgedAged, 80 and overAge DistributionCross-Sectional StudiesEthnicityEuropeEuropean UnionFemaleHumansMaleMiddle AgedMyopiaPrevalenceRisk Factors

Identifiers

PMID25983215
PMCPMC4504030
OpenAlexW2110370370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.